Martin F. Jackson - May 26, 2021 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Role
Executive Vice President
Signature
/s/ Michael E. Tarvin, as attorney-in-fact
Stock symbol
SEM
Transactions as of
May 26, 2021
Transactions value $
-$8,034,000
Form type
4
Date filed
5/28/2021, 04:06 PM
Previous filing
May 25, 2021
Next filing
Jun 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SEM Common Stock Sale -$4.02M -100K -7.22% $40.15 1.29M May 26, 2021 Direct F1
transaction SEM Common Stock Sale -$4.02M -100K -7.78% $40.19 1.19M May 27, 2021 Direct F2
holding SEM Common Stock 2.63K May 26, 2021 By son F3
holding SEM Common Stock 2.63K May 26, 2021 By son F3
holding SEM Common Stock 2.63K May 26, 2021 By daughter F3
holding SEM Common Stock 2.63K May 26, 2021 By son F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.39, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.05 to $40.56, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.